Upharmacia January 2017

RETAIL DRUG SALES: + 0.4 % HOSPITAL DRUG SALES:-6.4 %

>> PHARMACEUTICAL MARKET: LOCAL PLAYERS GROWTH

Market participants are striving to further development.——

HALYCHPHARM( a part of the Arterium Corporation) has launched an infusion solutions line.

——

On May 17, INTERCHEM has opened a new laboratory and production complex in Odessa. The company invested EUR 42 mio in enhancing its industrial capacities, which would allow increasing its production by 4 times.

——

At the beginning of the year, DARNITSA was endorsed to acquire a little bit more than 50 % shares of the Borshchahivskiy Chemical Pharmaceutical Plant( BCPP). The Board of BCPP accused Darnitsa of hostile takeover attempts. The acquisition process was halted.

——

Ukrainian company KUSUM PHARM plans to start enlargement of its plant in Sumy by the end of 2016 to double production capacity at least 2 times by 2018.

——

In May, Ukrainian company PHARMASCO opened its own complex, which includes offices, warehouse with appropriate temperature conditions and premises for own production.

——

In Dec, EBRD announced the provision of USD 3.8 mio loan to Ukrainian company ECOPHARM for the construction of GMP plant. The Bank will also provide USD 3 mio loan to PHARMA-START( part of Swiss ACINO GROUP) for equipment procurement and additional capitalization.

>> PHARMACEUTICAL MARKET: FOREIGN EXPANSION

Ukrainian pharmaceutical companies were actively exploring new markets:——

In Jan, FARMAK acquired polish distributor KWW Kotkowski Wierzbicki Wegrzyn sp. j.

—— In Sep, ARTERIUM acquired Slovenian company Marifarm.

—— In Oct, FARMAK announced plans to enter the Malasian market in 2018.

—— In Oct, BIOFARMA signed a long-term agreement on export of its products to the Republic of Yemen.

——

ZDOROVYE GROUP plans to access the U. S. market within the cooperation with the American company Unicity.

——

LEKHIM’ S company Technolog announced the intention to triple exports of its antituberculosis drugs in next few years.

—— In Dec, FARMAK joined Drug, Chemical & Associated Technologies Association( DCAT) in order to have the opportunity to access the U. S. market.

6 www. upharma-c. com